This May Explain Horizon Pharma's 20% Plunge

Loading...
Loading...
Shares of
Horizon Pharma PLCHZNP
plunged more than 20 percent on Tuesday after the company released an
investor presentation which included a revenue outlook. Horizon Pharma said that it expects its 2016 revenue to be in a range of $1.025 billion to $1.05 billion and adjusted EBITDA to be in a range of $505 million to $520 million. As noted by
Seeking Alpha's news editor,
Horizon Pharma's revenue guidance for the first quarter may be in a range of $195 million to $210 million (the company guided towards a 79 percent year-over-year growth at midpoint) - falling short of the $228 million Wall Street analysts were expecting.
Posted In: NewsGuidanceHorizon Pharmapharmaceutical stocksSeeking Alpha News
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...